| Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma RD Morin, M Mendez-Lago, AJ Mungall, R Goya, KL Mungall, RD Corbett, ... Nature 476 (7360), 298-303, 2011 | 1796 | 2011 |
| Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ... Journal of clinical oncology 30 (28), 3452, 2012 | 1067 | 2012 |
| EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation W Béguelin, R Popovic, M Teater, Y Jiang, KL Bunting, M Rosen, H Shen, ... Cancer cell 23 (5), 677-692, 2013 | 862 | 2013 |
| A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications GW Wright, JD Phelan, ZA Coulibaly, S Roulland, RM Young, JQ Wang, ... Cancer cell 37 (4), 551-568. e14, 2020 | 644 | 2020 |
| Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue DW Scott, GW Wright, PM Williams, CJ Lih, W Walsh, ES Jaffe, ... Blood, The Journal of the American Society of Hematology 123 (8), 1214-1217, 2014 | 624 | 2014 |
| The tumour microenvironment in B cell lymphomas DW Scott, RD Gascoyne Nature Reviews Cancer 14 (8), 517-534, 2014 | 511 | 2014 |
| The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022 | 472 | 2022 |
| Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ... Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013 | 449 | 2013 |
| Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ... Journal of clinical oncology 33 (26), 2848, 2015 | 411 | 2015 |
| The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development A Ortega-Molina, IW Boss, A Canela, H Pan, Y Jiang, C Zhao, M Jiang, ... Nature medicine 21 (10), 1199-1208, 2015 | 398 | 2015 |
| CNS international prognostic index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP N Schmitz, S Zeynalova, M Nickelsen, R Kansara, D Villa, LH Sehn, ... Journal of Clinical Oncology 34 (26), 3150-3156, 2016 | 384 | 2016 |
| Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ... Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014 | 310 | 2014 |
| Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma D Ennishi, A Jiang, M Boyle, B Collinge, BM Grande, S Ben-Neriah, ... Journal of Clinical Oncology 37 (3), 190, 2019 | 283 | 2019 |
| Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP LH Sehn, DW Scott, M Chhanabhai, B Berry, A Ruskova, L Berkahn, ... J clin oncol 29 (11), 1452-1457, 2011 | 270 | 2011 |
| Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ... The Journal of pathology 224 (3), 328-333, 2011 | 260 | 2011 |
| Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial KL Tan, DW Scott, F Hong, BS Kahl, RI Fisher, NL Bartlett, RH Advani, ... Blood, The Journal of the American Society of Hematology 120 (16), 3280-3287, 2012 | 244 | 2012 |
| CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... Cancer discovery 7 (1), 38-53, 2017 | 239 | 2017 |
| Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition D Ennishi, K Takata, W Béguelin, G Duns, A Mottok, P Farinha, ... Cancer discovery 9 (4), 546-563, 2019 | 222 | 2019 |
| Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical … AM Staiger, M Ziepert, H Horn, DW Scott, TFE Barth, HW Bernd, AC Feller, ... Journal of clinical oncology 35 (22), 2515-2526, 2017 | 215 | 2017 |
| Histological transformation and progression in follicular lymphoma: a clonal evolution study R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ... PLoS medicine 13 (12), e1002197, 2016 | 207 | 2016 |
Randy D GascoyneProfessor of Pathology, University of British ColumbiaVerified email at bccancer.bc.ca
